(Q36382582)

13 August 2017

1 reference

title

Fungal infections in bone marrow transplant recipients (English)

1 reference

13 August 2017

Tuhina Raman

1

1 reference

13 August 2017

Paul E Marik

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Expert Opinion on Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

307-315

1 reference

Outcome of bone marrow transplantation patients requiring mechanical ventilation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Iron gathering of opportunistic pathogenic fungi. A mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Immunity to Aspergillus fumigatus: the basis for immunotherapy and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Modern management of respiratory failure due to pulmonary mycoses following allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Microbiological diagnosis of invasive fungal infections in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Long-term antifungal prophylaxis in high-risk hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Fungal infections in patients undergoing blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.3.307

21 January 2018

Identifiers

DOI

10.1517/14656566.7.3.307

1 reference

13 August 2017

1 reference